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ABSTRACT
Background and Objective: In recent years, the inci-
dence of endometrial cancer has gradually increased in
Korea, and the use of laparoscopically assisted staging
surgery (LASS) is increasing in this field. We conducted
this study to evaluate the feasibility of LASS in Korean
women with endometrial cancer.
Methods: We conducted a retrospective review of 35
Korean women with endometrial cancer who were man-
aged laparoscopically.
Results: The median age and BMI were 57 years (range,
28 to 81) and 25.8 kg/m
2 (range, 20.9 to 37.2), respec-
tively. The median operating time, estimated blood loss,
and length of hospital stay were, respectively, 150 minutes
(range, 95 to 410), 250 mL (range, 50 to 1000), and 8 days
(range, 3 to 20). No conversion to laparotomy was noted.
The median number of harvested lymph nodes was 22
(range, 10 to 41) in pelvic lymph nodes and 7 (range, 2 to
21) in paraaortic lymph nodes. No vault recurrence or
port-site metastasis was noted until the last follow-up.
Conclusions: LASS can be performed without additional
morbidity and complications, and might be feasible in
Korean women with endometrial cancer.
Key Words: Endometrial cancer, Laparoscopy, Lymphad-
enectomy.
INTRODUCTION
Since Childers et al1 initially reported the laparoscopic
surgical management of 2 cases of stage I endometrial
cancer, many studies have advocated the advantages of
laparoscopically assisted staging surgery (LASS) compared
with laparotomic staging surgery in women with endome-
trial cancer. Laparoscopic surgical management has com-
parable clinical outcomes to those of conventional lapa-
rotomy; it results in less pain and bleeding, shorter
hospital stay, and faster recovery to normal activities thus
improving quality of life.2–12
Of gynecologic malignancies, endometrial cancer is the
third most prevalent following cervical cancer and ovarian
cancer in Korean women. In recent years, the incidence of
endometrial cancer has gradually increased.13
In the present study, to examine feasibility, effectiveness,
and any complications of LASS in Korean women with
endometrial cancer, we reviewed women who underwent
LASS and compared our operative data results with those
of other studies.
METHODS
Of 39 women who were diagnosed with endometrial
cancer at Kangbuk Samsung Hospital between August
2003 and November 2007, we excluded 4 women who
refused to undergo laparoscopic surgery or were ineligi-
ble for laparoscopic surgery because of concurrent car-
diopulmonary diseases; a final number of 35 women were
enrolled in the present study. The preoperative workup
included medical history, physical examination, pelvic
examination, gynecologic ultrasonography, Pap smear,
endometrial biopsy, and MRI. The previous abdominal
surgical history and body mass index (BMI) did not affect
our decision to perform staging surgery in all women.
After being informed of the characteristics depending on
the extent of surgery, such as complications and their
incidence, and the necessity of staging surgery, each
woman gave informed consent. The operating time was
defined as the period from trocar insertion to closure of
the port site.
Before August 2005, when American College of Obstetri-
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SCIENTIFIC PAPERcians and Gynecologists (ACOG) clinical guidelines for
management of endometrial cancer was published,14 10
women with endometrial cancer were managed by lapa-
roscopically assisted vaginal hysterectomy (LAVH) and
bilateral salpingo-oophorectomy (BSO) with laparoscopic
pelvic lymphadenectomy (LPL). Laparoscopic paraaortic
lymphadenectomy (LPAL) was then added to LAVH and
BSO with LPL after August 2005. However, the decision to
perform LPAL was not influenced by adhesion and obe-
sity.
LASS was performed according to the following proce-
dure. Intravenous preoperative prophylactic antibiotics
were administered: cefminox2go rflomocef1gi fa
woman was allergic to cephalosporins. Preoperative
bowel preparation with Fleet Phospho-soda was done in
all cases. Women were placed in a dorsal lithotomy posi-
tion and given general anesthesia with endotracheal intu-
bation, and the surgical preparation was performed asep-
tically using Povidone-iodine. The port placement system
was established through Choi’s 4-trocar method,15 and the
intraabdominal pressure was maintained at 15mm Hg.
After the entire abdominal and pelvic cavities were thor-
oughly examined, peritoneal washing cytology was per-
formed; multiple biopsies were performed for any sus-
pected area in the abdominal cavity. To prevent the
retrograde spread of cancer cells through both tubes, the
tube containing both round and ovarian ligaments was
ligated by the extracorporeal endosuture technique (Su-
ture LapLoop, Sejong Medical, Seoul, Korea.). Subse-
quently, a uterine elevator (Uterine grasping forceps by
Sairges, WOLF, Germany) was inserted. Prior to LAVH,
LPL was systemically performed from the level corre-
sponding to the deep circumflex iliac vein to the level of
the ureter crossing the common iliac artery. While LPAL
was being performed, neither additional trocar insertion
nor positional change of the operator or a monitor, or
both, was done. LPAL was performed to the level of the
left renal vein using a dissector with monopolar coagula-
tor and Harmonic shears (Ultracision Harmonic Scalpel,
Ethicon Endo-Surgery, Cincinnati, OH) (Figure 1). The
dissected lymphatic tissues were safely removed through
the opened vaginal vault after LAVH with BSO.
Following the completion of all surgical procedures,
drainage (Evacuator Barovac, Sewoon Medical, Seoul, Ko-
rea) was inserted after confirming ureteric peristalsis and
that no bleeding was occurring at the trocar site or in the
abdominal cavity. To minimize the “chimney effect,” CO2
gas was released gradually and completely. After remov-
ing the trocars, the trocar sites were dressed with Povi-
done-iodine, and the sites of skin incision were sutured.
Statistical Analysis
Data are expressed as the median and range. The Student
t test was used to compare the number of harvested lymph
nodes between the right and left pelvic lymph node.
P0.05 was taken to indicate a significant difference. All
statistical analyses were performed using SAS version 9.1
(SAS Institute Inc., Cary, NC, USA).
RESULTS
The median age and BMI were 57 years (range, 28 to 81)
and 25.8 kg/m
2 (range, 20.9 to 37.2). Eighteen women
(51.4%) had some concomitant medical disease: hyperten-
sion in 12 women (34.3%), diabetes in 8 (22.9%), ischemic
heart disease in 1 (2.9%), and other medical diseases in 3
(8.6%). Fourteen women (40.0%) had a history of previous
abdominal surgery: laparoscopic tubal ligation in 8
women (22.9%), cesarean delivery in 5 (14.3%), appen-
dectomy in 2 (5.7%), tubal reversal in 1 (2.9%), and sal-
pingectomy due to tubal pregnancy in 1 (2.9%). Operative
techniques included LAVH with BSO in 1 patient (2.9%)
who was a 76-year-old woman with Parkinson’s disease,
cerebrovascular accident, diabetes, and hypertension;
LAVH with BSO combined with LPL in 9 (25.7%); LAVH
with BSO combined with LPL and LPAL in 24 (68.6%);
hysteroscopic tumorectomy with LPL in 1 (2.9%) for fer-
tility conservation16; laparoscopic modified radical vaginal
hysterectomy with BSO, LPL, and LPAL in one (2.9%) with
an MRI finding that tumor had invaded the uterine cer-
vix.17 Median operating time and estimated blood loss
were 150 minutes (range, 95 to 410) and 250mL (range, 50
to 1,000), respectively. No conversion to laparotomy was
noted. Intraoperative complications included 1 case
(2.9%) of inferior vena cava laceration, in which laparo-
scopic primary repair was done using a Prolene 5–0 su-
ture. Thereafter, no additional complications were re-
ported. Postoperative complications were noted in 3
women (8.6%): lymphocyst in 1 woman, lymphedema of
the right leg in 1, and a high fever (38° C) within 48
postoperative hours in one. In these 3 cases, the symp-
toms improved with conservative therapy. Median length
of hospital stay was 8 days (range, 3 to 20). Peritoneal
washing cytology was negative in all women. The median
number of harvested lymph nodes was 22 (range, 10 to
41) in pelvic lymph nodes; 12 (range, 5 to 21) in right
pelvic lymph nodes; 11 (range, 4 to 21) in left pelvic
lymph nodes; and 7 (range, 2 to 21) in paraaortic lymph
nodes. No statistical difference was found in the number
of harvested lymph nodes between the right and left
pelvic lymph node (P0.9523). Three women had his-
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Two women had a histopathological finding of paraaortic
lymph node metastasis. No women had both pelvic and
paraaortic lymph node metastases.
The detailed histopathological results and FIGO stage are
shown in Table 1. In postoperative adjuvant treatment, 5
women in stage IIIc were treated through chemo-radia-
tion therapy with paclitaxel and carboplatin.18 Ten
women without lymph node metastasis beyond stage Ib
were treated with external radiation therapy or vault ra-
diation. For one woman who underwent hysteroscopic
tumorectomy with LPL for fertility conservation, medroxy-
progesterone acetate (500 mg/day) was prescribed for 16
months.19
Median follow-up was 22 months (range, 1 to 47). No
vault recurrence or port-site metastases were noted until
the last follow-up. Distant metastasis was found in the
Table 1.
Histopathological Results
Histology Number (%)
Endometrioid 31 (88.6)
Mixed 2 (5.7)
Endometroid & mucinous 1 (2.9)
Papillary and poorly differentiated 1 (2.9)
Malignant Mixed Mu ¨llerian Tumor 2 (5.7)
Grade
G1 26 (74.3)
G2 7 (20.0)
G3 0 (0)
FIGO Stage
Ia 19 (54.3)
Ib 4 (11.4)
Ic 3 (8.6)
IIa 1 (2.9)
IIb 3 (8.6)
IIIc 5 (14.3)
Figure 1. An actual laparoscopic image after laparoscopic trans-
peritoneal lymphadenectomy. A: (1) left external iliac artery, (2)
left external iliac vein, (3) left obturator nerve, (4) left ureter. B:
(1) right external iliac artery, (2) right external iliac vein, (3) right
obturator nerve, (4) right ureter. C: (1) aorta, (2) inferior vena
cava, (3) inferior mesenteric artery, (4) left renal vein, (5) right
ovarian vein, and (6) left ovarian vein.
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chemotherapy is currently in process.
DISCUSSION
Since 1988, laparotomic staging surgery via a midline
incision has been done in women with endometrial can-
cer. The staging surgery included total abdominal hyster-
ectomy with bilateral salpingo-oophorectomy, peritoneal
washing cytology, the sampling of paraaortic and pelvic
lymph nodes, and the dissection.20 Since then, total vag-
inal hysterectomy has been considered an alternative sur-
gical modality to laparotomy in a high-risk group of wom-
en; however, it has several disadvantages as a surgical
approach.21 Laparoscopic staging surgery has overcome
these disadvantages by causing less pain, shorter hospital
stay, and in addition, providing the ability to inspect the
abdominal cavity.2–12
A meta-analysis of many studies concerning laparoscopic
surgery for endometrial cancer reports the problems due
to the differences in the patient groups, surgical methods,
surgeons’ high technical expertise, and the extent and
frequency of lymph node dissection. Table 2 summarizes
results from previous studies regarding FIGO stage, the
extent and frequency of lymph node dissection, the num-
ber of harvested lymph nodes, complications, operating
time, the amount of bleeding, and the length of hospital
Table 2.
Comparisons of Previous Studies on Laparoscopic Surgery of Endometrial Cancer*
Study No. of
Patients
Stage Number of Harvested
LN†
Number (%) W/
Complications†
Operative Time
(min)
EBL (mL) Hospital Stay
(days)
Malur et al (2001)
2 37 I–III Pelvic LN: 16.1(7.6) 11 (29.7) 176.4 (85.4) 229.2 (190.2) 8.6 (2.7)
Paraaortic LN: 9.6(7.6)
Eltabbakh et al (2001)
3 86 I–IV Pelvic LN: 10.8(5.0) IOC: 2(2.3) 190.5 (48.9) 278.3 (207.2) 2.5 (2.4)
Paraaortic LN: 2.7(1.9) POC: 8(9.3)
Fram (2002)
4 29 I Pelvic LN: 21.3 3 (10.3) 136.2 145.5 2.3
Paraaortic LN: none
Tozzi et al (2005)
5 63 I–III Pelvic LN: 19.3(13–37) - - 241.3 7.8
Paraaortic LN: 12.3(10–
21)
Sobiczewski et al.
(2005)
6
45 I–III 8(2–21) 11(23) 120 (67–240) - 5 (2–13)
Zapico et al (2005)
7 38 I–II Pelvic LN: 15.06(1.44) IOC: 5(13.2) 164.91 (5.60) - 5.04 (2.7)
Paraaortic LN: none POC: 7(18.4)
Wong et al (2005)
8 19 I–III Pelvic LN: 26.1 (11.0) IOC: 0(0) 211 (32) 200 (78) 3 (2–8)
Paraaortic LN: none POC: 2(10.5)
Ghezzi et al (2006)
9 37 I–IV Pelvic LN: 18(7–31) IOC: 3(8.1) 213.2 (39.4) 150 (50–450) 3 (1–6)
Paraaortic LN: none POC: 7(18.9)
Frigerio et al (2006)
10 55 I–III Pelvic LN: 18.5 IOC: 2(3.6) 220 (80–375) 285 (100–800) 4
Paraaortic LN: none POC: 6(10.9)
Gil-Moreno et al
(2006)
11
55 I–III Pelvic LN: 16.64(5.6) IOC: 2(4.7) 192 (38.5) 250 (100–700) 4 (2–13)
Paraaortic LN:
7.04(3.4)
POC: 6(14.3)
Current Study 35 I–III Pelvic LN: 22(10–41) IOC: 1(2.9) 150 (95–410) 250 (50–1000) 8 (3–20)
Paraaortic LN: 7(2–21) POC: 3(8.6)
*Data are presented as median (range) or mean  SD.
†LN  Lymph node; IOC  Intraoperative complication; POC  Postoperative complication; EBL  Estimated blood loss.
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derwent LPL and LPAL compared with those in the previ-
ous studies, no significant differences were found in the
incidence of complications, the amount of bleeding, and
the median number of harvested lymph nodes. However,
the median operating time seems relatively shorter. Sev-
eral factors might be involved in determining the operat-
ing time, but the following matters contributed to short-
ening the operating time in our series. Korean women
with endometrial cancer have lower BMI than do western
women. Through the 4-trocar method,15 laparoscopic sur-
geons can obtain better surgical vision and manipulate
instruments easily; additionally, despite the extended
scope of lymph node dissection, no additional insertion of
trocars was necessary, and the operator and monitor were
not required to move or be moved for LPAL. In our series,
median BMI was 25.8kg/m
2 (range, 20.9 to 37.2). One
woman (2.9%) had a high degree of obesity (BMI35kg/
m
2), and 2 women (5.7%) were obese (BMI30kg/m
2).
Kim et al22 reported that mean BMI was 23.1kg/m
2 in
Korean women 20 years of age. According to these
authors, women with a high degree of obesity were rare
compared with those in a Western population. Our find-
ings support these reports, and such findings were as-
sumed to shorten the operating time. However, mean
length of hospital stay was relatively longer. Presumably,
this might be due to the structural problems of the health
insurance system as well as the tendency of Korean
women wanting to be discharged after complete recovery
of their normal activities.
In addition, some controversial issues have been raised
regarding the management of endometrial cancer using
LASS; these include the intraabdominal dissemination of
cancer cells (eg, the increase in positive peritoneal wash-
ing cytology), port-site metastasis, and the recurrence of
vaginal vault, which are all caused by intraabdominal
leakage due to the use of a uterine elevator.23–25 To pre-
vent the intraabdominal leakage of cancer cells and port-
site metastasis, we ligated both oviducts by using the
extracorporeal endosuture technique before insertion of
the uterine elevator. After trocar insertion, the trocars were
tightly fixed with precaution to assure affixation, and all
the extracts were removed via the vaginal route. Intraop-
erative peritoneal washing cytology was negative. To
date, no cases of port-site metastasis or vaginal vault
recurrence have been reported.
CONCLUSION
Although continuing a large, prospective, and randomized
study is necessary, we believe that LASS can be performed
without additional morbidity and complications, and is
feasible and effective in Korean women with endometrial
cancer.
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